IMP Dehydrogenase and GTP as Targets in Human Leukemia Treatment

This publication has 10 references indexed in Scilit:

• Regulation of de novo and salvage pathways in chemotherapy
  Advances in Enzyme Regulation, 1991
• Tiazofurin: Biological effects and clinical uses
  The International Journal of Cell Cloning, 1990
• Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia
  Advances in Enzyme Regulation, 1988
• IMP dehydrogenase: Inhibition by the anti-leukemic drug, tiazofurin
  Leukemia Research, 1988
• Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K-562 leukemia cells.
  Proceedings of the National Academy of Sciences, 1988
• Selective sensitivity to tiazofurin of human leukemic cells
  Biochemical Pharmacology, 1986
• Biochemical mechanisms of resistance to tiazofurin
  Advances in Enzyme Regulation, 1985
• Nucleoside and Nucleotide Inhibitors of Inosine Monophosphate (IMP) Dehydrogenase as Potential Antitumor Inhibitors
  Nucleosides and Nucleotides, 1982
• Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expression
  Advances in Enzyme Regulation, 1976
• IMP dehydrogenase, an enzyme linked with proliferation and malignancy
  Nature, 1975